Blog

Seek truth from facts, competitive symbiosis

scroll down

Announcement on the Amendment to the Articles of Association and Changes in Registered Capital of Hunan Zhengqing Pharmaceutical Group Co., Ltd.

Release time:

2021-04-28


       The Board of Directors and all Directors of the Company guarantee that there are no false statements, misleading representations, or significant omissions in this announcement, and they shall bear legal responsibility for the truthfulness, accuracy, and completeness of its content.

 

      Hunan Zhengqing Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") has obtained the approval from the China Securities Regulatory Commission for its targeted issuance of shares to specific recipients (hereinafter referred to as "this targeted issuance"), as per the "Reply on Approving the Targeted Issuance of Shares by Hunan Zhengqing Pharmaceutical Group Co., Ltd." (CSRC Approval [2020] No. 2165), approving the Company's targeted issuance of no more than 134,000,000 new shares.

      The Company completed this targeted issuance in April 2021, issuing a total of 134,000,000 RMB ordinary shares to 6 specific recipients at an issuance price of RMB 3.5 per share, raising funds amounting to RMB 469,000,000, of which the newly added registered capital (share capital) is RMB 134,000,000.

Based on the results of this targeted issuance and the authorization from the Company's General Meeting of Shareholders, the Company has amended relevant clauses in its "Articles of Association". Article 4 of Chapter 1 has been revised to "The Company's registered capital is RMB 204,270,346"; Article 16 of Chapter 3 has been revised to "The total number of shares of the Company is 204,270,346 shares". Currently, the Company has completed the industrial and commercial registration procedures for the "Articles of Association" and registered capital changes, and has obtained a new "Business License". This targeted issuance has been completed in accordance with legal procedures.

The Company will subsequently handle the registration and custody procedures at Hunan Equity Registration and Management Center Co., Ltd.

This is hereby announced.

 

Hunan Zhengqing Pharmaceutical Group Co., Ltd.

Board of Directors

April 23, 2021